Hutch News

Hutch News

Stories tagged 'VIDD Research Interests'

Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life

June 7, 2019 | By Fred Hutch News Service staff

A new study led by physicians at Fred Hutchinson Cancer Research Center shows that patients with HIV and one of a variety of potentially deadly cancers can be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

View story >


Engineering vaccine-like protection without a vaccine

CRISPR gene-editing used on antibody-making B cells

May 17, 2019 | By Sabin Russell / Fred Hutch News Service

A Hutch team led by Dr. Justin Taylor shows that B cells, which are crucial components of the immune system, can be genetically engineered to make exactly the antibodies we want. It could lead to a potentially more precise and dependable way to generate protection without vaccines.

View story >


London transplant doctors report a 2nd person likely cured of HIV

12 years after Timothy Ray Brown was cured, we have another

March 5, 2019 | By Sabin Russell / Fred Hutch News Service

Seattle-born Timothy Ray Brown was once known as the “Berlin Patient” because that is where he lived when he became the first person in the world to be cured of HIV. On March 4, after 12 long years, there is now a “London Patient,” only the second person likely cured of HIV — and word about it came Monday at a scientific conference in Seattle.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.